Insmed Touts Strong BRINSUPRI Launch, Payer Access at RBC Conference
Insmed (NASDAQ:INSM) said BRINSUPRI’s launch is tracking ahead of expectations at an RBC Capital Markets fireside chat, citing strong payer access, patient support enrollment and steady new patient starts. CFO Sara reported 44% quarter-over-quarter growth and guidance of at least $1 billion. She also addressed discontinuation questions with real-world vs trial comparisons and discussed Japan timing and ARIKAYCE Phase 3 ENCORE updates.